Thalidomide inhibited the expression of pro-inflammatory mediators in vitro.
Thalidomide inhibited the expression of matrix metalloproteinases in vitro.
Thalidomide inhibited the expression of radiculopathic pain in vivo.
Thalidomide could treat pain and inflammation in degenerative disc disease.